Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Enterprise Value: 2018-2021

Historic Enterprise Value for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $193.1 million.

  • Black Diamond Therapeutics' Enterprise Value fell 76.97% to $193.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $193.1 million, marking a year-over-year increase of 443.85%. This contributed to the annual value of $121.1 million for FY2024, which is 16.54% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Enterprise Value of $193.1 million as of Q4 2021, which was up 170.60% from $71.4 million recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Enterprise Value ranged from a high of $1.3 billion in Q2 2020 and a low of -$154.7 million during Q4 2019.
  • Moreover, its 3-year median value for Enterprise Value was $185.2 million (2021), whereas its average is $345.9 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 199.39% in 2019, then spiked by 3,402.75% in 2020.
  • Over the past 4 years, Black Diamond Therapeutics' Enterprise Value (Quarterly) stood at -$51.7 million in 2018, then plummeted by 199.39% to -$154.7 million in 2019, then surged by 642.20% to $838.6 million in 2020, then plummeted by 76.97% to $193.1 million in 2021.
  • Its last three reported values are $193.1 million in Q4 2021, $71.4 million for Q3 2021, and $177.3 million during Q2 2021.